Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine as adjuvant to ropivacaine for popliteal nerve block
NCT01986751Phase 2Terminated
- Sponsor
- University of Alabama at Birmingham
- Start
- Jan 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of clonidine in postoperative pain, sponsored by University of Alabama at Birmingham. Primary endpoint: Mean Time to Onset of Sensory and Motor Block at 72 hours. Started Jan 2014; status: terminated.
02
Drugs
clonidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01986751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01986751.